These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Partial purification and characterization of insulin protease and its intracellular inhibitor from rat liver. McKenzie RA; Burghen GA Arch Biochem Biophys; 1984 Mar; 229(2):604-11. PubMed ID: 6367662 [TBL] [Abstract][Full Text] [Related]
7. Biological properties of an initial degradation product of insulin by insulin-degrading enzyme. Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Sakamoto T; Kawase Y; Akiyama H; Taketomi S; Baba S Endocrinology; 1989 Jan; 124(1):496-504. PubMed ID: 2642422 [TBL] [Abstract][Full Text] [Related]
8. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin. Duckworth WC; Hamel FG; Bennett R; Ryan MP; Roth RA J Biol Chem; 1990 Feb; 265(5):2984-7. PubMed ID: 1689296 [TBL] [Abstract][Full Text] [Related]
9. Purification and some properties of a myofibrillar protein-degrading protease, cathepsin L, from rabbit skeletal muscle. Okitani A; Matsukura U; Kato H; Fujimaki M J Biochem; 1980 Apr; 87(4):1133-43. PubMed ID: 7390982 [TBL] [Abstract][Full Text] [Related]
10. Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver. Ogawa W; Shii K; Yonezawa K; Baba S; Yokono K J Biol Chem; 1992 Jan; 267(2):1310-6. PubMed ID: 1730651 [TBL] [Abstract][Full Text] [Related]
11. Drosophila insulin degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites. Duckworth WC; Garcia JV; Liepnieks JJ; Hamel FG; Hermodson MA; Frank BH; Rosner MR Biochemistry; 1989 Mar; 28(6):2471-7. PubMed ID: 2659071 [TBL] [Abstract][Full Text] [Related]
12. Insulin-degrading enzyme is capable of degrading receptor-bound insulin. Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Amano K; Sakamoto T; Kawase Y; Akiyama H; Nagata M Biochem Biophys Res Commun; 1988 Jan; 150(2):605-14. PubMed ID: 3277630 [TBL] [Abstract][Full Text] [Related]
13. Characterization and partial purification of an insulinase from Neurospora crassa. Kole HK; Smith DR; Lenard J Arch Biochem Biophys; 1992 Sep; 297(2):199-204. PubMed ID: 1386721 [TBL] [Abstract][Full Text] [Related]
14. [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation. Williams FG; Johnson DE; Bauer GE Metabolism; 1990 Mar; 39(3):231-41. PubMed ID: 2407925 [TBL] [Abstract][Full Text] [Related]
15. Proteolytic degradation of insulin and glucagon. Duckworth WC; Heinemann M; Kitabchi AE Biochim Biophys Acta; 1975 Feb; 377(2):421-30. PubMed ID: 235306 [TBL] [Abstract][Full Text] [Related]
16. Purification and properties of acylamino acid-releasing enzyme from rat liver. Tsunasawa S; Narita K; Ogata K J Biochem; 1975 Jan; 77(1?):89-102. PubMed ID: 1137989 [TBL] [Abstract][Full Text] [Related]
17. Characterization of an intracellular insulin-degrading enzyme in human erythrocytes. Gambhir KK; Nerurkar SG Biochem Med Metab Biol; 1988 Jun; 39(3):284-9. PubMed ID: 3293635 [TBL] [Abstract][Full Text] [Related]
18. Covalent linkage of 125I-insulin to a cytosolic insulin-degrading enzyme. Shii K; Baba S; Yokono K; Roth RA J Biol Chem; 1985 Jun; 260(11):6503-6. PubMed ID: 3888982 [TBL] [Abstract][Full Text] [Related]
19. Purification to homogeneity of an insulin-degrading enzyme from human erythrocytes. Kolb HJ; Standl E Hoppe Seylers Z Physiol Chem; 1980 Jul; 361(7):1029-39. PubMed ID: 6997171 [TBL] [Abstract][Full Text] [Related]
20. Purification and properties of human liver peptidase. Sugiura M; Ito Y; Hirano K; Sawaki S Biochim Biophys Acta; 1977 Apr; 481(2):578-85. PubMed ID: 857895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]